Trials / Sponsors / Epitopoietic Research Corporation
Epitopoietic Research Corporation
Industry · 2 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | ERC1671 to Treat Malignant Gliomas When Given in Combination With GM-CSF, Cyclophosphamide, Bevacizumab and Pe Glioma, Malignant | Phase 2 | 2022-07-01 |
| Active Not Recruiting | ERC1671/GM-CSF/Cyclophosphamide for the Treatment of Glioblastoma Multiforme Glioblastoma, Gliosarcoma | Phase 2 | 2014-03-01 |